يعرض 1 - 10 نتائج من 39 نتيجة بحث عن '"Morissette, Rachel"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: Nature. 532(7598)

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Ganesh, Santhi K; Morissette, Rachel; Xu, Zhi; Schönhoff, Florian; Griswold, Benjamin F; Yang, Jiandong; Tong, Lan; Yang, Min-Lee; Hunker, Kristina; Sloper, Leslie; Kuo, Shinie; Raza, Rafi; Milewicz, Dianna M; Francomano, Clair A; Dietz, Harry C; Van Eyk, Jennifer; McDonnell, Nazli B (2014). Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB journal, 28(8), pp. 3313-3324. Federation of American Societies for Experimental Biology 10.1096/fj.14-251207

    مصطلحات موضوعية: 610 Medicine & health

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Ganesh, Santhi K.; Morissette, Rachel; Xu, Zhi; Schoenhoff, Florian; Griswold, Benjamin F.; Yang, Jiandong; Tong, Lan; Yang, Min‐lee; Hunker, Kristina; Sloper, Leslie; Kuo, Shinie; Raza, Rafi; Milewicz, Dianna M.; Francomano, Clair A.; Dietz, Harry C.; Van Eyk, Jennifer; McDonnell, Nazli B. (2014). "Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGFâ β expression and connective tissue features." The FASEB Journal 28(8): 3313-3324.; https://hdl.handle.net/2027.42/154380Test; The FASEB Journal; Gabay, C., and Kushner, I. ( 1999 ) Acuteâ phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448 â 454; Olin, J. W. ( 2012 ) Is fibromuscular dysplasia a single disease? Circulation 126, 2925 â 2927; Savard, S., Steichen, O., Azarine, A., Azizi, M., Jeunemaitre, X., and Plouin, P. F. ( 2012 ) Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation 126, 3062 â 3069; Tanaka, T., Scheet, P., Giusti, B., Bandinelli, S., Piras, M. G., Usala, G., Lai, S., Mulas, A., Corsi, A. M., Vestrini, A., Sofi, F., Gori, A. M., Abbate, R., Guralnik, J., Singleton, A., Abecasis, G. R., Schlessinger, D., Uda, M., and Ferrucci, L. ( 2009 ) Genomeâ wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 84, 477 â 482; Milhorat, T. H., Bolognese, P. A., Nishikawa, M., McDonnell, N. B., and Francomano, C. A. ( 2007 ) Syndrome of occipitoatâ lantoaxial hypermobility, cranial settling, and Chiari malformation type I in patients with hereditary disorders of connective tissue. J. Neurosurg. Spine 7, 601 â 609; Normand, J., and Karasek, M. A. ( 1995 ) A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin. In Vitro Cell. Dev. Biol. Anim. 31, 447 â 455; Tanner, F. C., Yang, Z. Y., Duckers, E., Gordon, D., Nabel, G. J., and Nabel, E. G. ( 1998 ) Expression of cyclinâ dependent kinase inhibitors in vascular disease. Circ. Res. 82, 396 â 403; Olin, J. W., Froehlich, J., Gu, X., Bacharach, J. M., Eagle, K., Gray, B. H., Jaff, M. R., Kim, E. S., Mace, P., Matsumoto, A. H., McBane, R. D., Klineâ Rogers, E., White, C. J., and Gornik, H. L. ( 2012 ) The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation 125, 3182 â 3190; Poloskey, S. L., Kim, E. S. H., Sanghani, R., Alâ Quthami, A. H., Arscott, P., Moran, R., Rigelsky, C. M., and Gornik, H. L. ( 2012 ) Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc. Med. 17, 371 â 378; Boden, S. D., Davis, D. O., Dina, T. S., Patronas, N. J., and Wiesel, S. W. ( 1990 ) Abnormal magneticâ resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J. Bone Joint Surg. Am. 72, 403 â 408; Boden, S. D., McCowin, P. R., Davis, D. O., Dina, T. S., Mark, A. S., and Wiesel, S. ( 1990 ) Abnormal magneticâ resonance scans of the cervical spine in asymptomatic subjects: a prospective investigation. J. Bone Joint Surg. Am. 72, 1178 â 1184; Dolan, A. L., Hart, D. J., Doyle, D. V., Grahame, R., and Spector, T. D. ( 2003 ) The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study. J. Rheumatol. 30, 799 â 803; Hakim, A. J., Cherkas, L. F., Grahame, R., Spector, T. D., and MacGregor, A. J. ( 2004 ) The genetic epidemiology of joint hypermobility: a population study of female twins. Arthritis Rheum. 50, 2640 â 2644; Matt, P., Schoenhoff, F., Habashi, J., Holm, T., Van Erp, C., Loch, D., Carlson, O. D., Griswold, B. F., Fu, Q., De Backer, J., Loeys, B., Huso, D. L., McDonnell, N. B., Van Eyk, J. E., and Dietz, H. C. ( 2009 ) Circulating transforming growth factorâ beta in Marfan syndrome. Circulation 120, 526 â 532; Rodrigues, V. J., Elsayed, S., Loeys, B. L., Dietz, H. C., and Yousem, D. M. ( 2009 ) Neuroradiologic manifestations of Loeysâ Dietz syndrome type 1. Am. J. Neuroradiol. 30, 1614 â 1619; Rose, P. S., Levy, H. P., Ahn, N. U., Sponseller, P. D., Magyari, T., Davis, J., and Francomano, C. A. ( 2000 ) A comparison of the Berlin and Ghent nosologies and the influence of dural ectasia in the diagnosis of Marfan syndrome. Genet. Med. 2, 278 â 282; Arnett, D. K., Jacobs, D. R., Jr., Luepker, R. V., Blackburn, H., Armstrong, C., and Claas, S. A. ( 2005 ) Twentyâ year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980â 1982 to 2000â 2002. Circulation 112, 3884 â 3891; D’Anglejan Chatillon, J., Ribeiro, V., Mas, J. L., Bousser, M. G., and Laplane, D. ( 1990 ) [Dissection of the extracranial internal carotid artery. 62 cases.] Presse Méd. 19, 661 â 667; Mas, J. L., Bousser, M. G., Hasboun, D., and Laplane, D. ( 1987 ) Extracranial vertebral artery dissections: a review of 13 cases. Stroke 18, 1037 â 1047; Shultz, S. J., Gansneder, B. M., Sander, T. C., Kirk, S. E., and Perrin, D. H. ( 2006 ) Absolute serum hormone levels predict the magnitude of change in anterior knee laxity across the menstrual cycle. J. Orthop. Res. 24, 124 â 131; Kisilevsky, R., and Manley, P. N. ( 2012 ) Acuteâ phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 19, 5 â 14; Nabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., and Derynck, R. ( 1993 ) Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 90, 10759 â 10763; Erkula, G., Sponseller, P. D., Paulsen, L. C., Oswald, G. L., Loeys, B. L., and Dietz, H. C. ( 2010 ) Musculoskeletal findings of Loeysâ Dietz syndrome. J. Bone Joint Surg. Am. 92, 1876 â 1883; Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., Xu, F. L., Myers, L. A., Spevak, P. J., Cameron, D. E., De Backer, J., Hellemans, J., Chen, Y., Davis, E. C., Webb, C. L., Kress, W., Coucke, P., Rifkin, D. B., De Paepe, A. M., and Dietz, H. C. ( 2005 ) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275 â 281; Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. ( 1994 ) Mechanism of activation of the TGFâ beta receptor. Nature 370, 341 â 347; Ling, S., Nheu, L., and Komesaroff, P. A. ( 2012 ) Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini. Rev. Med. Chem. 12, 175 â 183; Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., Di Pietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. ( 1992 ) Interleukinâ 8 as a macrophageâ derived mediator of angiogenesis. Science 258, 1798 â 1801; Li, A., Dubey, S., Varney, M. L., Dave, B. J., and Singh, R. K. ( 2003 ) ILâ 8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170, 3369 â 3376; Smith, W. B., Noack, L., Khewâ Goodall, Y., Isenmann, S., Vadas, M. A., and Gamble, J. R. ( 1996 ) Transforming growth factorâ beta 1 inhibits the production of ILâ 8 and the transmigration of neutrophils through activated endothelium. J. Immunol. 157, 360 â 368; Morissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fertâ Bober, J., Sloper, L., Lehman, J., Commins, N., Van Eyk, J. E., and McDonnell, N. B. ( 2014 ) Transforming growth factorâ beta and inflammation in vascular (type IV) Ehlersâ Danlos syndrome. Circ. Cardiovasc. Genet. 7, 80 â 88; Akhurst, R. J. ( 2012 ) The paradoxical TGFâ beta vasculopathies. Nat. Genet. 44, 838 â 839; Doyle, A. J., Doyle, J. J., Bessling, S. L., Maragh, S., Lindsay, M. E., Schepers, D., Gillis, E., Mortier, G., Homfray, T., Sauls, K., Norris, R. A., Huso, N. D., Leahy, D., Mohr, D. W., Caulfield, M. J., Scott, A. F., Destree, A., Hennekam, R. C., Arn, P. H., Curry, C. J., Van Laer, L., McCallion, A. S., Loeys, B. L., and Dietz, H. C. ( 2012 ) Mutations in the TGFâ beta repressor SKI cause Shprintzenâ Goldberg syndrome with aortic aneurysm. Nat. Genet. 44, 1249 â 1254; St Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlsonâ Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., Siegenthaler, M. P., Arduino, C., Mancini, C., Freudenthal, B., Stanescu, H. C., Zdebik, A. A., Chaganti, R. K., Nussbaum, R. L., Kleta, R., Gahl, W. A., and Boehm, M. ( 2011 ) NT5E mutations and arterial calcifications. N. Engl. J. Med. 364, 432 â 442; Aoyama, T., Francke, U., Gasner, C., and Furthmayr, H. ( 1995 ) Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am. J. Med. Genet. 58, 169 â 176; Tanemoto, M., Takase, K., Yamada, T., Satoh, A., Abe, T., and Ito, S. ( 2007 ) Dilation of renal artery stenosis after administration of losartan. Hypertens. Res. 30, 999 â 1002; Leadbetter, W. F., and Burkland, C. F. ( 1938 ) Hypertension in unilateral renal disease. J. Urol. 39, 611 â 626; Slovut, D. P., and Olin, J. W. ( 2004 ) Fibromuscular dysplasia. N. Engl. J. Med. 350, 1862 â 1871; Harrison, E. G., Jr., and McCormack, L. J. ( 1971 ) Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin. Proc. 46, 161 â 167; Stanley, J. C., and Fry, W. J. ( 1975 ) Renovascular hypertension secondary to arterial fibrodysplasia in adults: criteria for operation and results of surgical therapy. Arch. Surg. 110, 922 â 928; Olin, J. W., and Sealove, B. A. ( 2011 ) Diagnosis, management, and future developments of fibromuscular dysplasia. J. Vasc. Surg. 53, 826 â 836, e821; Stanley, J. C., Gewertz, B. L., Bove, E. L., Sottiurai, V., and Fry, W. J. ( 1975 ) Arterial fibrodysplasia: histopathologic character and current etiologic concepts. Arch. Surg. 110, 561 â 566; Stanley, J. C., and Whitehouse, W. M., Jr. ( 1984 ) Occlusive and aneurysmal disease of the renal arterial circulation. Dis. Mon. 30, 1 â 62; Wynn, T. A. ( 2008 ) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199 â 210; Gladstien, K., Rushton, A. R., and Kidd, K. K. ( 1980 ) Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin. Genet. 17, 115 â 116; Schievink, W. I., and Limburg, M. ( 1989 ) Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlersâ Danlos syndrome, type IV. Neurosurgery 25, 482 â 483; Milewicz, D. M., Kwartler, C. S., Papke, C. L., Regalado, E. S., Cao, J., and Reid, A. J. ( 2010 ) Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet. Med. 12, 196 â 203; Lancman, M., Mesropian, H., Serra, P., and Granillo, R. ( 1991 ) Turner’s syndrome, fibromuscular dysplasia, and stroke. Stroke 22, 269 â 271; Schievink, W. I., Bjornsson, J., and Piepgras, D. G. ( 1994 ) Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke 25, 2492 â 2496